SIM
RCKTW icon

Sandia Investment Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Sandia Investment Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-203,321
Closed -$26.6K – 261
2023
Q1 		$26.6K Buy
+203,321
New +$39.2K ﹤0.01% 207

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Sandia Investment Management's RCKTW Position: Q3 2023 in Review

Sandia Investment Management sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q3 2023, closing a stake of 203,321 shares — an estimated $38.6K sold.

Sandia Investment Management first reported a position in RCKTW in Q2 2023 and held it in 1 quarter. The position peaked at $38.6K in Q2 2023. 17 funds tracked by Wall St. Rank hold RCKTW as of Q3 2023.

  • Sandia Investment Management reported no remaining Rocket Pharmaceuticals Warrant position as of Q3 2023 after selling out during the quarter.
  • Sandia Investment Management sold 203,321 Rocket Pharmaceuticals Warrant shares in Q3 2023, an estimated $38.6K.
  • Sandia Investment Management first reported a position in Rocket Pharmaceuticals Warrant in Q2 2023 and held it in 1 quarter.
  • Sandia Investment Management's Rocket Pharmaceuticals Warrant position peaked at $38.6K in Q2 2023.
  • 17 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q3 2023.

Based on Sandia Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.